Osteoblast-Specific γ-Glutamyl Carboxylase-Deficient Mice Display Enhanced Bone Formation with Aberrant Mineralization

Journal of Bone and Mineral Research

Volumn 30, Issue 7, 2015, Pages 1245-1254

  Azuma, Kotaro ^a   Shiba, Sachiko ^b   Hasegawa, Tomoka ^c   Ikeda, Kazuhiro ^b   Urano, Tomohiko ^a   Horie Inoue, Kuniko ^b   Ouchi, Yasuyoshi ^a,d   Amizuka, Norio ^c   Inoue, Satoshi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d TORANOMON HOSPITAL   (Japan)

Author keywords

BONE FORMATION; GGCX; OSTEOBLASTS; VITAMIN K

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; PREGNANE X RECEPTOR; VITAMIN K DEPENDENT CARBOXYLASE; GLUTAMYL CARBOXYLASE; LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERALIZATION; BONE STRENGTH; COLLAGEN FIBER; CONTROLLED STUDY; CORTICAL BONE; ELECTRON MICROSCOPY; FEMALE; IMMUNOREACTIVITY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOID; OSTEOPENIA; SIGNAL TRANSDUCTION; TRABECULAR BONE; ANIMAL; ANTIBODY SPECIFICITY; BIOMECHANICS; BONE DEVELOPMENT; DEFICIENCY; ENZYMOLOGY; FEMUR; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIBIA; ULTRASTRUCTURE;

ANIMALS; BIOMECHANICAL PHENOMENA; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; CARBON-CARBON LIGASES; FEMUR; MICE; ORGAN SPECIFICITY; OSTEOBLASTS; OSTEOGENESIS; TIBIA;

EID: 84931834435     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2463     Document Type: Article

References (38)

1. Yaegashi Y, Onoda T, Tanno K, Kuribayashi T, Sakata K, Orimo H,. Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitamin K. Eur J Epidemiol. 2008; 23 (3): 219-25.
2. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ,. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166 (12): 1256-61.
3. Furie B, Bouchard BA, Furie BC,. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood. 1999; 93 (6): 1798-1808.
4. Azuma K, Ouchi Y, Inoue S,. Vitamin K novel molecular mechanisms of action and its roles in osteoporosis. Geriatr Gerontol Int. 2014; 14 (1): 1-7.
5. Hauschka PV, Lian JB, Gallop PM,. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA. 1975; 72 (10): 3925-29.
6. Tabb MM, Sun A, Zhou C, et al., Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem. 2003; 278 (45): 43919-27.
7. Azuma K, Casey SC, Ito M, et al., Pregnane X receptor knockout mice display osteopenia with reduced bone formation and enhanced bone resorption. J Endocrinol. 2010; 207 (3): 257-63.
8. Zhu A, Sun H, Raymond RM Jr, et al., Fatal hemorrhage in mice lacking gamma-glutamyl carboxylase. Blood. 2007; 109 (12): 5270-5.
9. Dacquin R, Starbuck M, Schinke T, Karsenty G,. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn. 2002; 224 (2): 245-51.
10. Ikeda K, Tsukui T, Tanaka D, Maruyama Y, Horie-Inoue K, Inoue S,. Conditional expression of human bone Gla protein in osteoblasts causes skeletal abnormality in mice. Biochem Biophys Res Commun. 2012; 424 (1): 164-9.
11. Ikeda K, Tsukui T, Horie-Inoue K, Inoue S,. Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice. FEBS Lett. 2011; 585 (9): 1303-9.
12. Azuma K, Tsukui T, Ikeda K, et al., Liver-specific γ-glutamyl carboxylase-deficient mice display bleeding diathesis and short life span. PLoS ONE. 2014; 9 (2): e88643.
13. Hasegawa T, Li M, Hara K, et al., Morphological assessment of bone mineralization in tibial metaphyses of ascorbic acid-deficient ODS rats. Biomed Res. 2011; 32 (4): 259-69.
14. Nishihara E, Nagayama Y, Inoue S, et al., Ontogenetic changes in the expression of estrogen receptor alpha and beta in rat pituitary gland detected by immunohistochemistry. Endocrinology. 2000; 141 (2): 615-20.
15. Villanueva AR, Lundin KD,. A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams. Stain Technol. 1989; 64 (3): 129-38.
16. Wada Y, Kataoka H, Yokose S, et al., Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. Bone. 1998; 22 (5): 479-85.
17. Amizuka N, Li M, Hara K, et al., Warfarin administration disrupts the assembly of mineralized nodules in the osteoid. J Electron Microsc. 2009; 58 (2): 55-5.
18. Shiba S, Ikeda K, Azuma K, et al., γ-Glutamyl carboxylase in osteoblasts regulates glucose metabolism in mice. Biochem Biophys Res Commun. 2014; 453 (3): 350-5.
19. Boskey AL, Wians FH Jr, Hauschka PV,. The effect of osteocalcin on in vitro lipid-induced hydroxyapatite formation and seeded hydroxyapatite growth. Calcif Tissue Int. 1985; 37 (1): 57-2.
20. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA, Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J. 1996; 317 (Pt 1): 59-4.
21. Ishida M, Amano S,. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. J Bone Miner Metab. 2004; 22 (5): 415-29.
22. Lee NK, Sowa H, Hinoi E, et al., Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130 (3): 456-69.
23. Ducy P, Desbois C, Boyce B, et al., Increased bone formation in osteocalcin-deficient mice. Nature. 1996; 382 (6590): 448-52.
24. Price PA, Urist MR, Otawara Y,. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun. 1983; 117 (3): 765-71.
25. Luo G, D'Souza R, Hogue D, Karsenty G,. The matrix Gla protein gene is a marker of the chondrogenesis cell lineage during mouse development. J Bone Miner Res. 1995; 10 (2): 325-34.
26. Luo G, Ducy P, McKee MD, et al., Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997; 386 (6620): 78-81.
27. Julien M, Khoshniat S, Lacreusette A, et al., Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1. J Bone Miner Res. 2009; 24 (11): 1856-68.
28. Murshed M, Schinke T, McKee MD, Karsenty G,. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol. 2004; 165 (5): 625-30.
29. Nakamura YS, Hakeda Y, Takakura N, et al., Tyro 3 receptor tyrosine kinase and its ligand, Gas6, stimulate the function of osteoclasts. Stem Cells. 1998; 16 (3): 229-38.
30. Asawa Y, Amizuka N, Hara K, et al., Histochemical evaluation for the biological effect of menatetrenone on metaphyseal trabeculae of ovariectomized rats. Bone. 2004; 35 (4): 870-80.
31. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J,. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem. 2008; 283 (26): 17991-18001.
32. Rios H, Koushik SV, Wang H, et al., Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol. 2005; 25 (24): 11131-44.
33. Casey SC, Nelson EL, Turco GM, Janes MR, Fruman DA, Blumberg B,. B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor. SXR. Mol Endocrinol. 2011; 25 (6): 933-43.
34. Suttie JW,. The biochemical basis of warfarin therapy. Adv Exp Med Biol. 1987; 214: 3-16.
35. Simon RR, Beaudin SM, Johnston M, Walton KJ, Shaughnessy SG,. Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats. Thromb Res. 2002; 105 (4): 353-8.
36. Haffa A, Krueger D, Bruner J, et al., Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. J Bone Miner Res. 2000; 15 (5): 872-8.
37. Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF,. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med. 2006; 166 (2): 241-6.
38. Jamal SA, Browner WS, Bauer DC, Cummings SR,. Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1998; 128 (10): 829-32.